Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets
Background. Currently, two genetic lineages of influenza B virus, B/Victoria and B/Yamagata, are cocirculating in humans in various countries. This situation has raised a question regarding the possibility of cross-protection between B components of live attenuated influenza vaccine (LAIV) belonging...
Main Authors: | Irina Kiseleva, Elena Krutikova, Ekaterina Stepanova, Svetlana Donina, Maria Pisareva, Vera Krivitskaya, Andrey Rekstin, Erin Grace Sparrow, Guido Torelli, Larisa Rudenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2018/9695628 |
Similar Items
-
Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014.
by: Mpho Seleka, et al.
Published: (2017-01-01) -
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus?
by: Irina Kiseleva, et al.
Published: (2019-06-01) -
The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century.
by: Saverio Caini, et al.
Published: (2019-01-01) -
Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model.
by: Larisa Rudenko, et al.
Published: (2018-01-01) -
Two Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets
by: Larisa Rudenko, et al.
Published: (2018-11-01)